01228.HK
CANbridge Pharmaceuticals Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 1.92
−0.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 35.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 34.72x
- PEG TTM
- —
- Price / book
- -2.18x
- Price / sales
- 14.93x
- Price / cash flow
- -19.53x
Enterprise value
- Enterprise value
- HKD 811.9M
- EV / sales
- 13.92x
- EV / EBITDA
- -8.74x
- EV / EBIT
- -7.51x
- Market cap
- HKD 870.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025